Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Humanized T Cell Receptor-like Antibody Hu8F4 Reduces Leukemia By Fc-Mediated Mechanism

Blood (2022) 140 (Supplement 1): 9061–9062.

https://doi.org/10.1182/blood-2022-162593

Published: 2022

Journal Articles

A Novel Approach to Reduce Toxicity and Preserve Efficacy of Chimeric Antigen Receptor T Cells for Adoptive Transfer

Rolando A. Vedia, Sijie Lu, Anne Philip, Anna Sergeeva, Lisa St John, Karen Clise-Dwyer, Jeffrey J. Molldrem

Blood (2022) 140 (Supplement 1): 10269–10270.

https://doi.org/10.1182/blood-2022-158603

Published: 2022

Journal Articles

Pembrolizumab in Combination with Antigen-Specific Cytotoxic T Lymphocytes Enhances Killing of Acute Myeloid Leukemia

Amber Gibson, Mao Zhang, Pariya Sukhumalchandra, Anne V. Philips, Na Qiao, Alexander A. Perakis, Celine Kerros, Lisa St. John, Karen Clise-Dwyer, Sijie Lu, Qing Ma, Jeffrey J. Molldrem, Gheath Alatrash

Blood (2021) 138 (Supplement 1): 2775.

https://doi.org/10.1182/blood-2021-149318

Published: 2021

Journal Articles

Identification of Myeloperoxidase As a Leukemia-Associated Antigen and Therapeutic Target for Acute Myeloid Leukemia

Eran Tallis, Sijie Lu, PhD, Xiaoling Ding, Dan Li, PhD, Kathryn Ruisaard, M. James You, MD PhD, Lisa St. John, Gheath Alatrash, DO, PhD, Qing Ma, PhD, Jeffrey J. Molldrem, MD

Blood (2017) 130 (Supplement 1): 4460.

https://doi.org/10.1182/blood.V130.Suppl_1.4460.4460

Published: 2017

Journal Articles

Cathepsin G Is Broadly Expressed By AML and Is an Effective Immunotherapeutic Target Against AML in Vivo

Gheath Alatrash, DO, PhD, Mao Zhang, MPH, Pariya Sukhumalchandra, BS, Yihua Qiu, MD, Amjad H. Talukder, PhD, Vladimir Senyukov, PhD, Lisa S. St. John, PhD, Hong He, MD, Anna Sergeeva, PhD, Jason Roszik, PhD, Karen Clise-Dwyer, PhD, Sijie Lu, PhD, Qing Ma, PhD, Elizabeth A. Mittendorf, MD PhD, Dean A. Lee, MD PhD, David H Hawke, PhD, Lizee Gregory, PhD, Jeffrey J. Molldrem, Steven M. Kornblau, MD

Blood (2014) 124 (21): 3761.

https://doi.org/10.1182/blood.V124.21.3761.3761

Published: 2014

Journal Articles

PR1 Is Cross-Presented By Multiple Myeloma Cells in Patients and Renders Multiple Myeloma Susceptible to PR1-CTL and Anti-PR1/HLA-A2 Antibody

Gheath Alatrash, DO, PhD, Pariya Sukhumalchandra, BS, Mao Zhang, MPH, Celine Kerros, PhD, Anna Sergeeva, PhD, Amanda Cernosek, BS, Haroon Jakher, BS, Madhushree Zope, Rebecca Patenia, MS, Lisa St John, PhD, Alexander Perakis, BA, Karen Dwyer, PhD, Ken H. Young, MD PhD, Jinsheng Weng, PhD, Sijie Lu, PhD, Elizabeth A. Mittendorf, MD PhD, Larry W Kwak, MD PhD, Qing Ma, PhD, Jeffrey J. Molldrem, MD

Blood (2014) 124 (21): 2133.

https://doi.org/10.1182/blood.V124.21.2133.2133

Published: 2014

Journal Articles

A GVHD kill switch helps immune reconstitution

Jeffrey J. Molldrem, Sijie Lu

Blood (2014) 123 (25): 3849–3850.

https://doi.org/10.1182/blood-2014-05-572883

Published: 2014

Journal Articles

Membrane-Associated Proteinase 3 On Granulocytes and Myeloid Leukemia Mediates Reversible Inhibition of T Cell Proliferation Associated with Altered ZAP70 and ERK Signaling

Tian-Hui Yang, MD, PhD, Karen Clise-Dwyer, PhD, S Lisa, St. John, PhD, Gheath Alatrash, DO, PhD, Kathryn Ruisaard, MS, Sijie Lu, PhD, Jeffrey J. Molldrem, MD

Blood (2012) 120 (21): 1031.

https://doi.org/10.1182/blood.V120.21.1031.1031

Published: 2012

Journal Articles

Multiple Myeloma Cross-Presents Neutrophil Elastase and Proteinase 3 and Becomes Susceptible to PR1-Targeting Immunotherapy

Gheath Alatrash, DO, PhD, Pariya Sukhumalchandra, BS, Mao Zhang, MPH, Anna Sergeeva, PhD, Haroon Jakher, BS, Jinsheng Weng, Ph.D, Lisa S St. John, PhD, Kathryn Ruisaard, BS, Karen Clise-Dwyer, PhD, Sijie Lu, PhD, Jeffrey J. Molldrem, MD

Blood (2012) 120 (21): 4973.

https://doi.org/10.1182/blood.V120.21.4973.4973

Published: 2012

Journal Articles

A Novel HLA-A2 Restricted Peptide Derived From Cathepsin G Is An Effective Immunotherapeutic Target for Myeloid Leukemia

Mao Zhang, MPH, Pariya Sukhumalchandra, BS, Atim A. Enyenihi, PhD, Lisa S St. John, PhD, Sally A. Hunsucker, PhD, Kathryn Ruisaard, MS, Zein Al Atrache, Patricia A Ropp, PhD, Tania Rodriguez-Cruz, BS, Elizabeth Mittendorf, MD, Gregory Lizee, PhD, Karen Clise-Dwyer, PhD, Sijie Lu, PhD, Gary L. Glish, PhD, Jeffrey J. Molldrem, MD, Paul M Armistead, MD, PhD, Gheath Alatrash, D.O., Ph.D.

Blood (2011) 118 (21): 2986.

https://doi.org/10.1182/blood.V118.21.2986.2986

Published: 2011

Journal Articles

An anti–PR1/HLA-A2 T-cell receptor–like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells

Anna Sergeeva, Gheath Alatrash, Hong He, Kathryn Ruisaard, Sijie Lu, James Wygant, Bradley W. McIntyre, Qing Ma, Dan Li, Lisa St John, Karen Clise-Dwyer, Jeffrey J. Molldrem

Blood (2011) 117 (16): 4262–4272.

https://doi.org/10.1182/blood-2010-07-299248

Published: 2011

Includes: Supplemental data

Journal Articles

Cellular Uptake of Soluble Neutrophil Elastase Increases Cyclin E (CCNE) Isoform Expression and Significantly Augments Susceptibility of Breast Cancer Cells to Cytolysis by CCNE-Specific Cytotoxic T Lymphocytes

Elizabeth Mittendorf, M.D., Gheath Alatrash, Na Qiao, Pariya Sukhumalchandra, Sijie Lu, Kathryn Quintanilla, Karen Clise-Dwyer, PhD, Jeffrey J. Molldrem, MD

Blood (2010) 116 (21): 2090.

https://doi.org/10.1182/blood.V116.21.2090.2090

Published: 2010

Journal Articles

Proteinase 3 Mediates Enzyme-Independent Reversible Inhibition of CD4 and CD8 T Cell Proliferation by Blocking G 1 -S Transition

Tian-Hui Yang, MD., PhD, Gheath Alatrash, DO, PhD, Karen Clise-Dwyer, PhD, Kathryn Quintanilla, MS, Sijie Lu, PhD, Jeffrey J. Molldrem, MD

Blood (2010) 116 (21): 2099.

https://doi.org/10.1182/blood.V116.21.2099.2099

Published: 2010

Journal Articles

Peripheral Tolerance to PR1 Is Maintained After Uptake of Soluble Proteinas-3 and Neutrophil Elastase

Gheath Alatrash, DO, PhD, Yoko Ono, MD, Anna Sergeeva, PhD, Pariya Sukhumalchandra, BS, Mao Zhang, MPH, Kathryn Quintanilla, MS, Paul Armistead, MD, PhD, Hong He, MD, Tania Rodriguez-Cruz, BS, Karen Clise-Dwyer, PhD, Eric Wieder, PhD, Greg Lizee, PhD, Sijie Lu, PhD, Jeffrey J. Molldrem, MD

Blood (2010) 116 (21): 4301.

https://doi.org/10.1182/blood.V116.21.4301.4301

Published: 2010

Journal Articles

Anti-PR1/HLA-A2 Antibody (8F4, A TCR-Mimic) Mediates Specific Lysis of AML Stem Cells but Not Normal Hematopoietic Stem Cells.

Anna Sergeeva, Ph.D., Gheath Alatrash, D.O., Ph.D., Karen Clise-Dwyer, Ph.D., Kathryn E Quintanilla, Sijie Lu, Ph.D., Qing Ma, Ph.D., Dan Li, Ph.D., Yang Wang, M. James You, M.D., Ph.D., Jeffrey J. Molldrem, M.D.

Blood (2009) 114 (22): 15.

https://doi.org/10.1182/blood.V114.22.15.15

Published: 2009

Journal Articles

T-Cell Immunity to Two HLA-A2-Restricted Self-Determinants of Cyclin E May Contribute to Remission After Stem Cell Transplantation.

Hong He, M.D., Ph.D., Ken Ishiyama, M.D., Ph.D., Gheath Alatrash, D.O., Ph.D., Yukio Kondo, M.D., Ph.D., Sijie Lu, Ph.D., Jeffrey J. Molldrem, M.D.

Blood (2009) 114 (22): 686.

https://doi.org/10.1182/blood.V114.22.686.686

Published: 2009

Journal Articles

Genomics as a Tool for Antigen Discovery in Allogeneic Stem Cell Transplantation: Identification of the Minor Antigen T4A through Donor/Patient Polymorphism Disparities

Paul Armistead, Shoudan Liang, Sijie Lu, Cornelis A.M. van Bergen, J.H.F. Falkenburg, Jeffrey J. Molldrem

Blood (2008) 112 (11): 3907.

https://doi.org/10.1182/blood.V112.11.3907.3907

Published: 2008

Journal Articles

Direct Visualization of PR1/HLA-A2 on the Membrane of HLAA2+ CD13+CD33+ Myeloid Leukemia Blasts by a Novel Monoclonal Antibody

Anna Sergeeva, Sijie Lu, James N Wygant, Gheath Alatrash, Kathryn Quintanilla, Jeffrey J. Molldrem, MD

Blood (2008) 112 (11): 2545.

https://doi.org/10.1182/blood.V112.11.2545.2545

Published: 2008

Journal Articles

Aberrant Subcellular Localization of Azurophil Granule Proteins in Myeloid Leukemia Favors Peptide Antigen Presentation on MHC-I and Susceptibility to Killing by Cytotoxic T Lymphocytes.

Gheath Alatrash, DO, PhD, Yoko Ono, Ph.D., Sijie Lu, Ph.D., Anna Sergeeva, Ph.D., Changqing Wang, M.D., Eric Wieder, Ph.D., Jeffrey J. Molldrem, M.D.

Blood (2007) 110 (11): 4900.

https://doi.org/10.1182/blood.V110.11.4900.4900

Published: 2007

Journal Articles

PR1 Vaccine Elicited Immunological Response after Hematopoietic Stem Cell Transplantation Is Associated with Better Clinical Response and Event-Free Survival.

Muzaffar H. Qazilbash, MD, Eric D. Wieder, PhD, Peter F. Thall, PhD, MS, BS, Xuemei Wang, MS, Rosa L. Rios, Sijie Lu, PhD, Shreya Kant, PhD, Sergio A. Giralt, MD, Elihu H. Estey, MD, Jorge Cortes, MD, Krishna Komanduri, MD, Richard E. Champlin, MD, Jeffrey J. Molldrem, MD

Blood (2007) 110 (11): 577.

https://doi.org/10.1182/blood.V110.11.577.577

Published: 2007

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Humanized T Cell Receptor-like Antibody Hu8F4 Reduces Leukemia By Fc-Mediated Mechanism

A Novel Approach to Reduce Toxicity and Preserve Efficacy of Chimeric Antigen Receptor T Cells for Adoptive Transfer

Pembrolizumab in Combination with Antigen-Specific Cytotoxic T Lymphocytes Enhances Killing of Acute Myeloid Leukemia

Identification of Myeloperoxidase As a Leukemia-Associated Antigen and Therapeutic Target for Acute Myeloid Leukemia

Cathepsin G Is Broadly Expressed By AML and Is an Effective Immunotherapeutic Target Against AML in Vivo

PR1 Is Cross-Presented By Multiple Myeloma Cells in Patients and Renders Multiple Myeloma Susceptible to PR1-CTL and Anti-PR1/HLA-A2 Antibody

A GVHD kill switch helps immune reconstitution

Membrane-Associated Proteinase 3 On Granulocytes and Myeloid Leukemia Mediates Reversible Inhibition of T Cell Proliferation Associated with Altered ZAP70 and ERK Signaling

Multiple Myeloma Cross-Presents Neutrophil Elastase and Proteinase 3 and Becomes Susceptible to PR1-Targeting Immunotherapy

A Novel HLA-A2 Restricted Peptide Derived From Cathepsin G Is An Effective Immunotherapeutic Target for Myeloid Leukemia

An anti–PR1/HLA-A2 T-cell receptor–like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells

Cellular Uptake of Soluble Neutrophil Elastase Increases Cyclin E (CCNE) Isoform Expression and Significantly Augments Susceptibility of Breast Cancer Cells to Cytolysis by CCNE-Specific Cytotoxic T Lymphocytes

Proteinase 3 Mediates Enzyme-Independent Reversible Inhibition of CD4 and CD8 T Cell Proliferation by Blocking G 1 -S Transition

Peripheral Tolerance to PR1 Is Maintained After Uptake of Soluble Proteinas-3 and Neutrophil Elastase

Anti-PR1/HLA-A2 Antibody (8F4, A TCR-Mimic) Mediates Specific Lysis of AML Stem Cells but Not Normal Hematopoietic Stem Cells.

T-Cell Immunity to Two HLA-A2-Restricted Self-Determinants of Cyclin E May Contribute to Remission After Stem Cell Transplantation.

Genomics as a Tool for Antigen Discovery in Allogeneic Stem Cell Transplantation: Identification of the Minor Antigen T4A through Donor/Patient Polymorphism Disparities

Direct Visualization of PR1/HLA-A2 on the Membrane of HLAA2+ CD13+CD33+ Myeloid Leukemia Blasts by a Novel Monoclonal Antibody

Aberrant Subcellular Localization of Azurophil Granule Proteins in Myeloid Leukemia Favors Peptide Antigen Presentation on MHC-I and Susceptibility to Killing by Cytotoxic T Lymphocytes.

PR1 Vaccine Elicited Immunological Response after Hematopoietic Stem Cell Transplantation Is Associated with Better Clinical Response and Event-Free Survival.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only